Chimerix Inc reports results for the quarter ended in March - Earnings Summary

Chimerix

01/05/2024 14:33

* Chimerix Inc  CMRX.OQ  reported a quarterly adjusted loss
of 25
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of -24
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 22 cents per share. Wall Street expected
results to range from -26 cents to -17 cents per share.
    * Reported revenue was zero​; analysts expected $50.00
thousand. 
    * Chimerix Inc's reported EPS for the quarter was a loss
of 25
cents​.
    * The company reported a quarterly loss of $21.87 million.
    * Chimerix Inc shares had fallen by 11.3% this quarter and
lost 2.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Chimerix Inc is
$7.00 
This summary was machine generated from LSEG data May 1 at 01:32
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.22          -0.25          Missed
 Dec. 31 2023      -0.24          -0.20          Beat
 Sep. 30 2023      -0.23          -0.27          Missed
 Jun. 30 2023      -0.24          -0.21          Beat